PennyP1cker
7 years ago
Citrus Ranch MP in Indio Ca. Is Sold
Buyer is identified only as a prominent local investor.
Citrus Ranch, an approved master-planned golf course community in Indio, California, has been sold by Saxony Land Company to a buyer identified only as "a prominent local investor in the Coachella Valley, according to Land Advisors Organization of Irvine, which represented the seller and announced the deal.
The Citrus Ranch community will feature approximately 3,053 residential units that will range in density from 2.5 du/ac to 15 du/ac. Citrus Ranch will offer segmented products along with luxury amenities like a community pool/spa, clubhouse, parks, and a golf course. The community also will contain an 18-hole, 7,100 yard, par 72 golf course that will provide spectacular views of the surrounding communities and take advantage of the natural topography.
David Landes, a vp at Land Advisors, said, “The new owners of Citrus Ranch recognized the value of the previous approved Specific Plan. They plan to add value through various innovative new land uses and plans.”
Riverside County’s population is expected to increase by 1.2% each year until 2022, ultimately confirming the already optimistic vision of many home builders looking to expand into the county.
The Coachella Team of Land Advisors Organization will be coming to market soon with two additional masterplans: Escena in Palm Springs and Shadow View in Coachella. (Builder Magazine, Feb. 2018)
Comment: Too bad PHM didn't buy this land. I think golf developments are not the way to go, perhaps that's why PHM didn't buy it. I was thinking PHM could divest the golf portion or change the master plan and take out the golf making it something else instead like a man-made lake. It would be nice to see PHM focus more on Southern California.
PennyP1cker
7 years ago
Pulte Homes is developing a 229-home community in the Dr. Phillips area of Orlando with homes ranging from $500,000 to $2 million.
Atlanta-based Pulte purchased the land last year and has plans to invest several millions more in infrastructure. It will offer 13 floor plans at the Phillips Grove community, ranging from two to seven bedrooms and two-and-a-half to six-and-a-half bathrooms, plus two- or three-car garages. Home sizes will range from 2,000 square feet to more than 5,000 square feet and prices will reach the $2 million mark for lakefront home sites. The large homes with life-tested designs can be personalized to fit a family’s needs and style, Pulte says.
“We are very excited to bring our Phillips Grove community to life this year,” said Clint Ball, president of Pulte’s North Florida division, in a statement. “This is a prime opportunity for buyers looking for new construction in Dr. Phillips. Plus, there are very few opportunities to own a home on the Butler chain of lakes—that’s something exclusive we are able to offer. We believe this will be one of the most unique opportunities to come to the market in Orlando this year.”
Phillips Grove will also offer several luxury amenities including a gated entrance, resort-style pool with cabana and a summer kitchen, athletic courts, and included lawn care. The new community is located just minutes from I-4 and residents can easily access “Restaurant Row”, highly-rated schools, and shopping.
“With the wide-variety of floor plans and square footage, this community is for buyers who want to upgrade to new construction in one of Orlando’s top submarkets or those who already live in the area who may want to downsize,” said Ball. “That’s why this is such a highly-desirable community.”
Pre-sales for the home sites have begun and the grand opening is set for April with model homes available to tour. Pulte plans to incorporate their model home tours with the latest in virtual reality technology.
Phillips Grove is one of 13 projects Pulte plans to open in the Orlando area this year.
by Brian Croce
HighPeaks
9 years ago
Press Release: Patient Home Monitoring Posts Record Audited Year-end Financials; Releases Record First Quarter Revenue and Profit Figures
1/4/16, 9:00 AM
Patient Home Monitoring Posts Record Audited Year-end Financials; Releases Record First Quarter Revenue and Profit Figures
LAFAYETTE, LOUISIANA--(Marketwired - Jan. 4, 2016) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on the annuity-based healthcare services market in the US announced that it posted Audited financials for the year ended September 30, 2015. Along with the full year results, PHM released revenue and profit figures for the quarter ending December 31, 2015.
PHM is offering an ever-larger suite of products and services to an increased geographic footprint in the US. While investing in enrollment growth for all of its existing products and services, PHM's mission in the market has always been to offer newly reimbursed and high demand services and products to patients. These cutting edge products often offer higher margins and limited competition.
Fiscal First Quarter (Ended December 31, 2015)
Revenues are estimated to exceed $40,000,000 for the quarter, an increase of more than 293% from the same quarter a year ago and an increase of 36% from the previous quarter.
Adjusted EBITDA(1) is currently estimated to be approximately $8,000,000 for the quarter, an increase of more than 236% from the same quarter a year ago and an increase of more than 123% from the previous quarter.
Full results will be posted on SEDAR around the end of January 2016. PHM's management will hold an interactive earnings call to review the first quarter and full year financials in early February 2016.
Audited Full Year (October 1, 2014 through September 30, 2015)
Revenues were $71,704,531 for the full year, as compared to $21,191,600 for the prior year, an increase of 238%.
Adjusted EBITDA(1) was $11,818,221 for the full year, as compared to $4,354,683 for the prior year, an increase of 171%.
Key Financial Figures for Audited FY 2013-2015
Audited FY 2015 FY 2014 FY 2013
------------------- ----------- ----------- -----------
Revenue $71,704,531 $21,191,600 $ 3,975,742
Gross Margin $47,042,594 $13,594,711 $ 2,602,358
Gross Margin % 66% 64% 65%
Adjusted EBITDA(1) $11,818,221 $ 4,354,683 $(1,890,337)
Cash $51,592,888 $14,050,436 $ 3,360,823
------------------- ---------- ---------- ----------
Full results have been posted on SEDAR.
"The year-end results, coupled with the first quarter, provides a good perspective of PHM's tremendous and consistent growth," said Casey Hoyt, CEO of PHM. "In just over two years, PHM has grown from a company with about $1,000,000 of quarterly revenue to a company with over $40,000,000 of quarterly revenue, all while growing profitability, our balance sheet and EPS along the way. We have plenty of cash on hand, growing cash flow and limited debt. In 2016 we are well positioned to take advantage of our national footprint with a growing sales force and product and service lines."
About PHM
The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals. PHM is a positive cash flow and profitable company that serves patients with heart disease and other chronic health conditions, this operation is a platform for acquisitions and organic growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM's post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
(1) Adjusted EBITDA is defined as EBITDA excluding Stock Based Compensation, good will impairment and gains/losses on financial derivatives.
Adjusted EBITDA is a Non-IFRS measure the Company uses as an indicator of financial health, and excludes several items which may be useful in the consideration of the financial condition of the Company, including interest expense, taxes, depreciation, amortization, stock based compensation, good will impairment and gain/losses on financial derivatives.
Forward-Looking Statements
Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of PHM and anticipated events or results, are assumptions based on beliefs of PHM's senior management as well as information currently available to it. While these assumptions were considered reasonable by PHM at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, difficulty integrating newly acquired businesses, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected. This press release refers non-GAAP and non-IFRS financial measures that do not have standardized meaning prescribed by GAAP or IFRS. PHM's presentation of these financial measures may not be comparable to similarly titled measures used by other companies. These financial measures are intended to provide additional information to investors concerning PHM's performance.
Patient Home Monitoring Corp.
Dennis Wilson
Corporate Affairs
(949) 346-9488
Investorinfo@myphm.com
www.phmhometesting.com
(END) Dow Jones Newswires
01-04-16 0900ET
mlkrborn
12 years ago
PulteGroup beats by $0.07, misses on revs (PHM) 17.45 : Reports Q3 (Sep) earnings of $0.27 per share, ex-$0.03 tax benefit, $0.07 better than the Capital IQ Consensus Estimate of $0.20; revenues rose 14.1% year/year to $1.3 bln vs the $1.42 bln consensus. Higher revenue for the period was driven by a 6% increase in average selling price to $279,000, combined with a 5% increase in closings to 4,418 homes. Net new orders for the third quarter totaled 4,544 homes valued at $1.3 billion, an increase of 27% and 43%, respectively, over the prior year. The year-over-year increase in signups was generated from 7% fewer communities. On a unit basis, PulteGroup's quarter-end backlog was up 49% to 7,686 homes with a value of $2.2 billion, compared with a prior year backlog of 5,143 homes with a value of $1.4 billion. The Company's third quarter 2012 backlog is the highest dollar value since the second quarter of 2008. As detailed in a separate press release issued October 24, 2012, PulteGroup announced a tender offer for up to $1.0 billion face amount of certain of the Company's outstanding senior notes. The Company intends to fund the tender with cash on hand.
Level up your trading with our powerful tools and real-time insights all in one place.
Randy1111
9 years ago
brentkosta
9 years ago
glenn1919
12 years ago
Doc Holliday
13 years ago
Penny Roger$
13 years ago
dshade
13 years ago
Hot Features
Premium
